Derm Cases · Dermatology / Internal Medicine
OSCE — pruritus without primary rash: systemic work-up and targeted management
An 8-minute OSCE station on evaluating generalised itch with minimal primary skin findings, prioritising systemic causes (cholestasis, uraemia, iron deficiency, polycythaemia, lymphoma, drugs), and choosing cause-directed therapy over endless antihistamines.
On this page
Study tools
Target exams
NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on evaluating generalised itch with minimal primary skin findings, prioritising systemic causes (cholestasis, uraemia, iron deficiency, polycythaemia, lymphoma, drugs), and choosing cause-directed therapy over endless antihistamines.
Brief (to candidate)
A 58-year-old has severe generalised itch for 3 months with only excoriations. No primary eczematous plaques. He takes multiple drugs; exam shows no jaundice yet. You have 8 minutes to take a focused history, plan investigations, and outline initial management.
Candidate instructions
- Define pruritus sine materia / itch without primary rash vs secondary excoriations.
- Screen systemic causes with history and first-line labs.
- Recognise polycythaemia vera and haematologic red flags (aquagenic itch).
- Avoid defaulting solely to sedating antihistamines.
- Give skin barrier care plus cause-directed therapy principles.
Examiner checklist (mark each domain / 10)
| Domain | Key actions expected |
|---|---|
| Clinical frame | Generalised itch with only secondary changes (excoriations, prurigo nodules) demands systemic review, not only dermatitic treatment |
| Key causes | Cholestasis (including pregnancy ICP context elsewhere), chronic kidney disease/uraemia, iron deficiency, thyroid disease, polycythaemia vera (aquagenic itch), Hodgkin lymphoma, HIV, drugs, occult infestation if subtle burrows missed, psychogenic after organic screen |
| History pearls | Aquagenic itch → consider PV; nocturnal + contacts → scabies re-check; drug timeline; B symptoms; travel; wash practices |
| First-line work-up | FBC (and film if indicated), ferritin/iron studies, U&E, LFT ± bilirubin/bile acids if cholestasis suspected, glucose/TFT; consider CXR/further haematology if red flags; age-appropriate malignancy review when indicated[1][2] |
| Skin care | Emollients, soap substitutes, short cool baths, treat secondary infection/nodules; non-sedating antihistamines limited benefit if non-histaminergic |
| Cause-directed | Optimise dialysis/uraemic care; treat iron deficiency; haematology referral for PV; cholestatic pathways; gabapentinoid consideration in uraemic itch under guidance[1][3] |
| Red flags | Weight loss, night sweats, lymphadenopathy, progressive jaundice, abnormal blood counts |
Model key actions
- Treat itch without primary rash as a systemic symptom complex and order core labs.[2]
- Ask specifically for aquagenic itch and pursue polycythaemia when suggested.[1]
- Combine emollient care with cause-directed therapy rather than endless sedating antihistamines alone.[3]
Common errors
- Diagnosing “eczema” without primary lesions and giving only steroids.
- Missing scabies by not re-examining finger webs/genitalia.
- Ignoring FBC abnormalities / aquagenic itch.
- Chronic first-generation antihistamines as sole plan.
- No safety-net for B symptoms/malignancy.
References6ShowHide
- [1]Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 2023.PMID 37357958
- [2]Butler DC, Berger T, Elmariah S, et al. Chronic Pruritus: A Review. JAMA, 2024.PMID 38809527
- [3]Sunderkötter C, Wohlrab J, Hamm H. Scabies: Epidemiology, Diagnosis, and Treatment. Deutsches Arzteblatt international, 2021.PMID 34615594
- [4]Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. The Journal of dermatological treatment, 2019.PMID 29737895
- [5]Geisler AN, Phillips GS, Barrios DM, et al. Immune checkpoint inhibitor-related dermatologic adverse events. Journal of the American Academy of Dermatology, 2020.PMID 32454097
- [6]Mayo MJ, Carey E, Smith HT, et al. Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis Dig Dis Sci, 2023.PMID 35704252